Articles Alert

The determination of whether the crystal structure of a protein is the same as that in solution, and the ability to solve structures of proteins that do not form crystals, are issues that require a marriage of X-ray diffraction crystallography and nuclear magnetic resonance (NMR) spectroscopy. Here is the first solution of an X-ray structure using a previously obtained NMR structure. The differences in the structures for the short, 72-amino acid polypeptide are small but important. E.T. Baldwi

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The determination of whether the crystal structure of a protein is the same as that in solution, and the ability to solve structures of proteins that do not form crystals, are issues that require a marriage of X-ray diffraction crystallography and nuclear magnetic resonance (NMR) spectroscopy. Here is the first solution of an X-ray structure using a previously obtained NMR structure. The differences in the structures for the short, 72-amino acid polypeptide are small but important.

E.T. Baldwin, I.T. Weber, R. St. Charles, J.-C. Xuan, et al., "Crystal structure of interleukin-8: symbiosis of NMR and crystallography," PNAS, 88, 502-6, 15 January 1991. (National Cancer Institute, Frederick and Bethesda, Md.; et al.)

Genetic analysis of amino acid residues needed for proper protein folding (rather than subsequent function) is leading to a series of "patterns." The use of mutants that are temperature-sensitive for folding and secondary mutations that reverse the sensitivity maps ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies